首页|复方三七护脉汤合益气通冠汤对冠心病心绞痛患者中医证候积分的影响

复方三七护脉汤合益气通冠汤对冠心病心绞痛患者中医证候积分的影响

扫码查看
目的 分析复方三七护脉汤合益气通冠汤对冠心病心绞痛患者中医证候积分的影响。方法 选取江苏盛泽医院 2022 年 3月~2023 年 12 月 80 例冠心病心绞痛患者,随机分成两组。对照组(40 例)采用常规西药治疗,研究组(40 例)采用复方三七护脉汤合益气通冠汤治疗。比较两组临床疗效、血脂水平、中医证候积分、心肌损伤情况、不良反应。结果 治疗前,两组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)比较差异无统计学意义(P>0。05),治疗后,研究组TC、TG、LDL-C低于对照组,HDL-C高于对照组(P<0。05);治疗前两组胸闷、胸痛、心悸及中医证候总积分比较差异无统计学意义(P>0。05),治疗后研究组胸闷、胸痛、心悸及中医证候总积分低于对照组(P<0。05);研究组总有效率高于对照组(P<0。05);两组乏力、恶心、呕吐总发生情况差异无统计学意义(P>0。05);治疗前两组肌酸激酶同工酶(CK-MB)、肌钙蛋白I(cTnI)、B型利钠肽(BNP)差异无统计学意义(P>0。05),治疗后研究组CK-MB、cTnI、BNP低于对照组(P<0。05)。结论 复方三七护脉汤合益气通冠汤治疗冠心病心绞痛患者效果较好,可改善患者临床症状、疼痛情况、心肌损伤情况,减少患者中医证候积分,且具有较高的安全性。
The influence of compound Sanqi Humai Decoction and Yiqi Tongguan Decoction on TCM syndrome score in patients with angina pectoris of coronary heart disease
Objective To analyze the influence of compound Sanqi Humai Decoction and Yiqi Tongguan Decoction on TCM syndrome score in patients with angina pectoris of coronary heart disease.Methods A total of 80 patients with coronary heart disease and angina pectoris in the Jiangsu Shengze Hospital from March 2022 to December 2023 were selected and randomly divided into two groups.The control group(40 cases)was treated with conventional western medicine,and the study group(40 cases)was treated with compound Sanqi Humai Decoction and Yiqi Tongguan Decoction.The clinical efficacy,blood lipid levels,TCM syndrome scores,myocardial injury and adverse reactions were compared between the two groups.Results Before treatment,there were no significant difference in TC,TG,HDL-C and LDL-C between the two groups(P>0.05).After treatment,TC,TG and LDL-C in the study group were lower than those in the control group,and HDL-C was higher than that in the control group(P<0.05).There were no significant difference in the total scores of chest tightness,chest pain,palpitation and TCM syndromes between the two groups before treatment(P>0.05).After treatment,the total scores of chest tightness,chest pain,palpitation and TCM syndromes in the study group were lower than those in the control group(P<0.05).The total effective rate of the study group was higher than that of the control group(P<0.05).There was no significant difference in the incidence of fatigue,nausea and vomiting between the two groups(P>0.05).There were no significant differences in CK-MB,cTnI and BNP between the two groups before treatment(P>0.05),and CK-MB,cTnI and BNP in the study group were lower than those in the control group after treatment(P<0.05).Conclusion Compound Sanqi Humai Decoction and Yiqi Tongguan Decoction has a good effect in the treatment of patients with coronary heart disease angina pectoris,which can improve the clinical symptoms and pain of patients,reduce the TCM syndrome score of patients,and has a high safety.

Compound Sanqi Humai DecoctionnYiqi Tongguan DecoctionCoronary heart disease angina pectorisTCM syndrome score

沈铭轩、李洋

展开 >

江苏盛泽医院中医科,江苏 苏州 215228

苏州市吴江区中医医院针灸科,江苏 苏州 215221

复方三七护脉汤 益气通冠汤 冠心病心绞痛 中医证候积分

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(10)